Abeona Therapeutics (ABEO) Accounts Payables (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Accounts Payables of $4.1 million for Q1 2026, down 18.87% year-over-year from $5.0 million in Q1 2025, and down 48.4% quarter-over-quarter from $7.9 million in Q4 2025.
Abeona Therapeutics (ABEO) Accounts Payables (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Accounts Payables history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 18.87% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 18.87% YoY), while the FY2025 annual figure was $7.9 million, up 129.26% from the prior year.
- Accounts Payables for Q1 2026 stood at $4.1 million, down from $7.9 million in the prior quarter.
- The five-year high for Accounts Payables was $7.9 million in Q4 2025, with the low at $1.6 million in Q1 2022.
- The 5-year median for Accounts Payables is $3.1 million (2024), against an average of $3.6 million.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables sank 58.13% in 2022, then surged 136.75% in 2025.
- Abeona Therapeutics' Accounts Payables stood at $1.8 million in 2022, then advanced by 2.6% to $1.9 million in 2023, then surged by 85.2% to $3.4 million in 2024, then jumped by 129.26% to $7.9 million in 2025, then plunged by 48.4% to $4.1 million in 2026.
- Business Quant data shows ABEO's Accounts Payables at $4.1 million in Q1 2026, $7.9 million in Q4 2025, and $5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 Mn |
| Mar 31, 2026 | 4.07 Mn |
| Dec 31, 2025 | 7.89 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 7.34 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 3.10 Mn |
| Mar 31, 2024 | 3.36 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 2.59 Mn |
| Jun 30, 2023 | 3.48 Mn |
| Mar 31, 2023 | 2.86 Mn |
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 4.33 Mn |
| Sep 30, 2021 | 1.86 Mn |